Yongheng Bai

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University · ORCID：0000-0003-3910-4731

发表论文 112 篇 · 总被引 2669 次 · h-index 28

代表论文

• Puerarin suppresses macrophage M1 polarization to alleviate renal inflammatory injury through antagonizing TLR4/MyD88-mediated NF-κB p65 and JNK/FoxO1 activation (2024 · Phytomedicine · 被引 74)
• S100A2 induces epithelial–mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner (2023 · Cell Death Discovery · 被引 21)
• Smad4 regulates TGF-β1-mediated hedgehog activation to promote epithelial-to-mesenchymal transition in pancreatic cancer cells by suppressing Gli1 activity (2024 · Computational and Structural Biotechnology Journal · 被引 19)
• Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy (2024 · Biomaterials · 被引 17)
• Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study (2023 · Lara D. Veeken · 被引 16)
• Inhibition of aquaporin-9 ameliorates severe acute pancreatitis and associated lung injury by NLRP3 and Nrf2/HO-1 pathways (2024 · International Immunopharmacology · 被引 15)